Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $7.7 million.

  • Prestige Consumer Healthcare's Depreciation & Amortization (CF) fell 3.35% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $30.2 million for FY2025, which is 1.64% down from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Depreciation & Amortization (CF) stood at $7.7 million, which was down 0.04% from $7.7 million recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Depreciation & Amortization (CF) peaked at $8.5 million during Q1 2022, and registered a low of $6.9 million during Q4 2024.
  • In the last 3 years, Prestige Consumer Healthcare's Depreciation & Amortization (CF) had a median value of $7.7 million in 2025 and averaged $7.6 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Depreciation & Amortization (CF) increased by 12.58% in 2022 and then fell by 10.18% in 2024.
  • Prestige Consumer Healthcare's Depreciation & Amortization (CF) (Quarterly) stood at $8.1 million in 2021, then rose by 0.99% to $8.1 million in 2022, then dropped by 5.95% to $7.6 million in 2023, then declined by 10.18% to $6.9 million in 2024, then declined by 3.35% to $7.7 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $7.7 million for Q3 2025, versus $7.7 million for Q2 2025 and $7.3 million for Q1 2025.